Journal of Gastroenterology

, Volume 41, Issue 4, pp 378–382

Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor

  • Hiroshi Nemoto
  • Genshu Tate
  • Annalisa Schirinzi
  • Takao Suzuki
  • Shoji Sasaya
  • Yasuo Yoshizawa
  • Takemasa Midorikawa
  • Toshiyuki Mitsuya
  • Bruno Dallapiccola
  • Yutaka Sanada
Case report

Abstract

Many mutations of the NF1 gene have been reported in patients with neurofibromatosis type 1 (NF1); however, there have been no documented NF1 gene mutations in Japanese NF1 patients. In the present study, we used the polymerase chain reaction (PCR) and DNA sequencing analysis to characterize the NF1 gene in a 53-year-old Japanese patient with NF1 who suffered from neurofibroma, pheochromocytoma, and gastrointestinal stromal tumor (GIST). Direct sequence analyses revealed a single base substitution in the splicing donor site of intron 6 (IVS6 888+1, G → A) in one NF1 allele, resulting in an altered splice site (ss) in the mutated allele. Splicing at the cryptic 5′ ss in the mutated allele generated mRNA with an insertion of 60 nucleotides. In addition, we screened for mutations in exons 9, 11, 13, and 17 of the c-kit gene in GIST and the succinate dehydrogenase subunit D (SDHD) gene in the pheochromocytoma, but we did not detect any somatic mutations. We report here the first case of an NF1 patient with four neoplasms: neurofibroma, pheochromocytoma, astrocytoma and GIST. Our results suggest that the molecular pathogenesis of GISTs in NF1 patients is different from that in non-NF1 patients.

Key words

neurofibromatosis type 1 gastrointestinal stromal tumor pheochromocytoma NF1 c-kit CD117 succinate dehydrogenase D 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Upadhyaya, M, Cooper, DN 1998

    The mutational spectrum in neurofibromatosis 1 and its underlying mechanisms

    Upadhyaya, MCooper, DN eds. Neurofibromatosis type 1: from genotype to phenotypeBios ScientificOxford6588
    Google Scholar
  2. 2.
    Cawthon, R, Weiss, R, Xu, G, Viskochil, D, Vulver, M, Stevens, J,  et al. 1990A major segment of neurofibromatosis type 1 gene: cDNA sequence genomic structure and point mutationsCell62193201PubMedCrossRefGoogle Scholar
  3. 3.
    Martin, GA, Viskochil, D, Bollag, G 1990The GAP-related domain of the NF1 gene interacts with ras p21Cell638439PubMedCrossRefGoogle Scholar
  4. 4.
    Li, Y, O'Connell, P, Breidenbach, HH, Cawthon, R, Stevens, J, Xu, G,  et al. 1995Genomic organization of the neurofibromatosis 1 gene (NF1)Genomics25918PubMedCrossRefGoogle Scholar
  5. 5.
    Fahsold, R, Hoffmeyer, S, Mischung, C, Gille, C, Ehlers, C, Kucukceylan, N,  et al. 2000Minor lesion mutational spectrum of the entire NF1 gene does not explain is high mutability but points to a functional domain upstream of the GAP-related domainAm J Hum Genet66790818PubMedCrossRefGoogle Scholar
  6. 6.
    Ars E, Kruyer H, Morell M, Pros E, Serra E, Ravella A, et al. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 2003;40–82Google Scholar
  7. 7.
    Thomson, SA, Fishbein, L, Wallace, MR 2002NF1 mutations and molecular testingJ Child Neurol1755561PubMedGoogle Scholar
  8. 8.
    De Luca, A, Schirinzi, A, Buccino, A, Bottillo, I, Sinibaldi, L, Torrente, I,  et al. 2004Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1Hum Mutat23629PubMedCrossRefGoogle Scholar
  9. 9.
    Kluwe, L, Fredrich, RE, Korf, B, Fahsold, R, Mautner, VF 2002NF1 mutation in neurofibromatosis 1 patients with plexiform neurofibromaHum Mutat1930913PubMedCrossRefGoogle Scholar
  10. 10.
    Yantiss, RK, Rosenberg, AE, Sarran, L, Besmer, P, Antonescu, CR 2005Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular studyMod Pathol1847584PubMedCrossRefGoogle Scholar
  11. 11.
    Hirota, S, Isozaki, K, Moriyama, Y, Hashimoto, K, Nishida, T, Ishiguro, S,  et al. 1998Gain-of-function mutations of c-kit in human gastrointestinal stromal tumorsScience27957780PubMedCrossRefGoogle Scholar
  12. 12.
    Williams, DE, Eisenman, J, Baird, A 1990Identification of a ligand for the c-kit proto-oncogeneCell6316774PubMedCrossRefGoogle Scholar
  13. 13.
    Yamaguchi, M, Tate, G, Endo, Y, Miyaki, M 2003Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumorsHepatogastroenterology5014315PubMedGoogle Scholar
  14. 14.
    Hirota, S, Nishida, T, Isozaki, K 2002Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT geneGastroenterology12214939PubMedCrossRefGoogle Scholar
  15. 15.
    Kinoshita, K, Isozaki, K, Hirota, S 2003c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumorsJ Gastroenterol Hepatol1814751PubMedCrossRefGoogle Scholar
  16. 16.
    Tate, G, Suzuki, T, Kishimoto, K, Mitsuya, T 2005A c-kit codon 816 mutation, D816H in the testicular germ cell tumor: case report of a Japanese patient with bilateral testicular seminomasActa Med Okayama59336PubMedGoogle Scholar
  17. 17.
    Kinoshita, K, Hirota, S, Isozaki, K, Ohashi, A, Nishida, T, Kitamura, Y,  et al. 2004Absence of c-kit gene mutations in gastrointestinal stromal tumors from neurofibromatosis type 1 patientsJ Pathol202805PubMedCrossRefGoogle Scholar
  18. 18.
    Frost, MJ, Ferrao, PT, Hughes, TP, Ashman, LK 2002Juxtamembrane mutant V560GKit is more sensitive to imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistantMol Cancer Ther1111524PubMedGoogle Scholar
  19. 19.
    Murata, H, Burgess, AW 1994Regulation of the Ras signaling networkBioessays1648996CrossRefGoogle Scholar
  20. 20.
    Xu, GF, O'Connell, P, Viskochil, D 1990The neurofibromatosis type 1 gene encodes a protein related to GAPCell62599608PubMedCrossRefGoogle Scholar
  21. 21.
    Linnekin, D 1999Early signaling pathways activated by c-kit in hematopoietic cellsInt J Biochem Cell Biol31105374PubMedCrossRefGoogle Scholar
  22. 22.
    Ning, ZQ, Li, J, Arceci, RJ 2001Signal transducer and activator of transcription 3 activation is required for Asp (816) mutant c-kit-mediated cytokine-independent survival and proliferation in human leukemia cellsBlood97355967PubMedCrossRefGoogle Scholar
  23. 23.
    Gimm, O, Armanios, M, Dziema, H 2000Somatic and occult germ-line mutations in SDHD a mitochondrial complex II gene, in nonfamilial pheochromocytomaCancer Res6068225PubMedGoogle Scholar
  24. 24.
    Neumann, PH, Bausch, B, McWhinney, SR 2002Germ-line mutations in nonsyndromic pheochromocytomaN Engl J Med346145966PubMedCrossRefGoogle Scholar
  25. 25.
    Ars, E, Serra, E, Garcia, J, Kruyer, H, Gaona, A, Lazaro, C,  et al. 2000Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1Hum Mol Genet923747PubMedCrossRefGoogle Scholar
  26. 26.
    Dasgupta, B, Gutmann, DH 2005Neurofibromin regulates neural stem cell proliferation, survival, and astroglia differentiation in vitro and in vivoJ Neurosci25558494PubMedCrossRefGoogle Scholar
  27. 27.
    O'Brien, P, Kapusta, L, Dardick, I, Axler J Gnidec, A 1999Multiple familial gastrointestinal nerve tumor and small intestinal neuronal dysplasiaAm J Surg Pathol23198204PubMedCrossRefGoogle Scholar
  28. 28.
    Takazawa, Y, Sakurai, S, Sakuma, Y, Ikeda, T, Yamaguchi, J, Hashizume, Y,  et al. 2005Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen' disease)Am J Surg Pathol2975563PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2006

Authors and Affiliations

  • Hiroshi Nemoto
    • 1
  • Genshu Tate
    • 2
  • Annalisa Schirinzi
    • 3
  • Takao Suzuki
    • 2
  • Shoji Sasaya
    • 1
  • Yasuo Yoshizawa
    • 1
  • Takemasa Midorikawa
    • 1
  • Toshiyuki Mitsuya
    • 2
  • Bruno Dallapiccola
    • 3
  • Yutaka Sanada
    • 1
  1. 1.Department of SurgeryShowa University Fujigaoka HospitalYokohamaJapan
  2. 2.Department of Surgical PathologyShowa University Fujigaoka HospitalYokohamaJapan
  3. 3.IRCCS-CSS, San Giovanni Rotondo and CSS-Mendel Institute, Department of Experimental Medicine and PathologyUniversity of Rome “La Sapienza”RomeItaly

Personalised recommendations